| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE SODIUM SUCCINATE | 22 |
| 1 | METHYLPREDNISOLONE | 16 |
| 2 | ADALIMUMAB | 15 |
| 3 | INFLIXIMAB | 15 |
| 4 | RITUXIMAB | 15 |
| 5 | ACETAMINOPHEN | 13 |
| 6 | ASPIRIN | 13 |
| 7 | SULFASALAZINE | 13 |
| 8 | ADALIMUMAB-AATY | 12 |
| 9 | ADALIMUMAB-ADAZ | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TROPICAMIDE | 8 | 0.0049 |
| 1 | CARBOXYMETHYLCELLULOSE SODIUM | 12 | 0.0021 |
| 2 | ALISKIREN HEMIFUMARATE | 10 | 0.0017 |
| 3 | ALBUMIN HUMAN | 8 | 0.0016 |
| 4 | ALBUMIN (HUMAN) | 8 | 0.0015 |
| 5 | AZATHIOPRINE SODIUM | 3 | 0.0012 |
| 6 | AMPICILLIN INJECTION | 8 | 0.0011 |
| 7 | KETOROLAC TROMETHAMINE | 5 | 0.0010 |
| 8 | AMPICILLIN | 8 | 0.0010 |
| 9 | GRANULOCYTE COLONY STIMULATING FACTOR | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 24 |
| 1 | Aminosalicylate [EPC] | 19 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 18 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 17 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 5 | Interleukin-23 Antagonist [EPC] | 13 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 7 | Antirheumatic Agent [EPC] | 12 |
| 8 | Interleukin-12 Antagonist [EPC] | 12 |
| 9 | RANK Ligand Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |
| 1 | Anticholinergic [EPC] | 8 | 0.0005 |
| 2 | Aminosalicylate [EPC] | 19 | 0.0002 |
| 3 | Macrolide Antimicrobial [EPC] | 8 | 0.0002 |
| 4 | Interleukin-23 Antagonist [EPC] | 13 | 0.0001 |
| 5 | Interleukin-12 Antagonist [EPC] | 12 | 0.0001 |
| 6 | Antirheumatic Agent [EPC] | 12 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 8 | Aldosterone Antagonist [EPC] | 10 | 0.0001 |
| 9 | Leukocyte Growth Factor [EPC] | 9 | 0.0001 |